UngBioTech, Virus-Eliminating Substance Now-St Receives FDA Human Safety Certification

[Asia Economy Reporter Hyunseok Yoo] Woong Bio Tech is building a consortium to prepare for new drug development after receiving Phase 1 certification from the FDA for human safety verification.

Woong Bio Tech announced on the 6th that it plans to expand its research institute and workforce through the consortium and will soon apply for FDA Phase 2 clinical trials.

Now-St is a substance developed by Woong Bio Tech using proprietary core technology, which in March of this year received test certification from the U.S. FDA for disinfection and sterilization that kills strains and viruses. During the certification process of Now-St, Escherichia coli, Staphylococcus, Salmonella, and Pseudomonas aeruginosa were eradicated by 99.9%. Additionally, the device manufacturing Now-St was certified to kill SARS by 95.6%.

It also successfully passed verification for human safety. Receiving certification that a disinfection and sterilization product killing strains and viruses is harmless to humans is not only the first case domestically but also rare worldwide.

A Woong Bio Tech official said, “After receiving FDA Phase 1 clinical certification, we are strengthening corporate competitiveness by expanding the research institute and recruiting excellent personnel, focusing on securing business references. We expect that through the formation of the consortium, we will be able to accelerate the progress of FDA Phase 2 clinical trials and business expansion.”

This content was produced with the assistance of AI translation services.